美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Revelation Biosciences, Inc.

0.0092

0.0000

成交量：4,000.00

成交額：27.96

市值：1.56萬

市盈率：0.00

高：0.0092

開：0.0066

低：0.0066

收：0.0092

52周最高：0.0218

52周最低：0.0055

股本：169.97萬

流通股本：169.97萬

量比：0.67

換手率：0.24%

股息：- -

股息率：- -

每股收益(TTM):-30.0050

淨資產收益率：-131.38%

總資產收益率：-62.28%

市淨率：0.00

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

Revelation Biosciences, Inc.盤中異動股價大跌5.44%

Revelation Biosciences, Inc.盤中異動股價大漲5.26%報1.60美元

Revelation Biosciences, Inc.盤中異動早盤股價大跌5.35%

Revelation Biosciences, Inc.盤中異動下午盤股價大漲6.08%

Revelation Biosciences, Inc.盤中異動早盤股價大漲5.34%

Revelation Biosciences, Inc.盤中異動下午盤快速下挫5.14%

Revelation Biosciences, Inc.盤中異動股價大漲7.44%報1.30美元

Revelation Biosciences, Inc.盤中異動早盤大幅下跌5.20%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/REVBW/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"REVBW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REVBW\",,,,,undefined,":{"symbol":"REVBW","market":"US","secType":"STK","nameCN":"Revelation Biosciences, Inc.","latestPrice":0.0092,"timestamp":1772658000000,"preClose":0.0092,"halted":0,"volume":4000,"delay":0,"changeRate":0,"floatShares":1699662,"shares":1699662,"eps":-30.005,"marketStatus":"盤後交易","change":0,"latestTime":"03-04 16:19:28 EST","open":0.0066,"high":0.0092,"low":0.0066,"amount":27.96,"amplitude":0.282609,"askPrice":0.0092,"askSize":5000,"bidPrice":0.0057,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-30.005,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1772672400000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0092,"volumeRatio":0.668025},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REVBW\",,,,,undefined,":{"symbol":"REVBW","floatShares":1699662,"roa":"-62.28%","roe":"-131.38%","lyrEps":0,"volumeRatio":0.668025,"shares":1699662,"dividePrice":0,"high":0.0092,"amplitude":0.282609,"preClose":0.0092,"low":0.0066,"week52Low":0.0055,"pbRate":"0.00","week52High":0.0218,"institutionHeld":0,"latestPrice":0.0092,"committee":-0.960784,"eps":-30.005,"divideRate":0,"volume":4000,"delay":0,"ttmEps":-30.005,"open":0.0066,"prevYearClose":0.008,"prevWeekClose":0.01,"prevMonthClose":0.01,"prevQuarterClose":0.008,"fiveDayClose":0.0101,"twentyDayClose":0.0091,"sixtyDayClose":0.01},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/REVBW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"REVBW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"REVBW\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"REVBW\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612446288","title":"Revelation Biosciences, Inc.盤中異動 股價大跌5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612446288","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612446288?lang=zh_tw&edition=fundamental","pubTime":"2026-02-18 04:59","pubTimestamp":1771361964,"startTime":"0","endTime":"0","summary":"北京时间2026年02月18日04时59分，Revelation Biosciences, Inc.股票出现波动，股价大幅下跌5.44%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Polaryx Therapeutics, Inc.、Cibus, Inc.、Nautilus Biotechnology, Inc.涨幅较大，Ensysce Biosciences, Inc.、Moolec Science Sa、Polaryx Therapeutics, Inc.较为活跃，换手率分别为839.76%、120.06%、114.02%，振幅较大的相关个股有Polaryx Therapeutics, Inc.、Ensysce Biosciences, Inc.、Cibus, Inc.，振幅分别为81.33%、74.28%、40.65%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc是一家临床阶段的生命科学公司，专注于通过其专有配方Gemini重新平衡炎症以优化健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218045925a70525fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218045925a70525fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REVBU","REVBW","REVB"],"gpt_icon":0},{"id":"2610952941","title":"Revelation Biosciences, Inc.盤中異動 股價大漲5.26%報1.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610952941","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610952941?lang=zh_tw&edition=fundamental","pubTime":"2026-02-11 02:12","pubTimestamp":1770747174,"startTime":"0","endTime":"0","summary":"北京时间2026年02月11日02时12分，Revelation Biosciences, Inc.股票出现波动，股价快速拉升5.26%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Quince Therapeutics, Inc.、Liminatus Pharma Inc C/Wts 30/04/2030 、Phio Pharmaceuticals Corp.涨幅较大，Abpro Holdings, Inc、Quince Therapeutics, Inc.、Phio Pharmaceuticals Corp.较为活跃，换手率分别为2488.96%、1823.75%、1344.76%，振幅较大的相关个股有Quince Therapeutics, Inc.、Abpro Holdings, Inc、Tuhura Biosciences, Inc.，振幅分别为169.08%、67.76%、50.61%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc是一家临床阶段的生命科学公司，专注于通过其专有配方Gemini重新平衡炎症以优化健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021102125497a5aec0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021102125497a5aec0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVBU","REVB","BK4139","REVBW"],"gpt_icon":0},{"id":"2607273724","title":"Revelation Biosciences, Inc.盤中異動 早盤股價大跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607273724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607273724?lang=zh_tw&edition=fundamental","pubTime":"2026-01-28 22:32","pubTimestamp":1769610738,"startTime":"0","endTime":"0","summary":"北京时间2026年01月28日22时32分，Revelation Biosciences, Inc.股票出现异动，股价大幅下挫5.35%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Liminatus Pharma Inc C/Wts 30/04/2030 、Pds Biotechnology Corporation、Gri Bio, Inc.涨幅较大，Gri Bio, Inc.、60 Degrees Pharmaceuticals, Inc.、Calcimedica, Inc.较为活跃，换手率分别为1745.54%、111.08%、64.48%，振幅较大的相关个股有Gri Bio, Inc.、Regenxbio Inc.、Cingulate Inc.，振幅分别为13.16%、9.81%、8.15%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc是一家临床阶段的生命科学公司，专注于通过其专有配方Gemini重新平衡炎症以优化健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012822321897a3d06d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012822321897a3d06d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVBW","BK4139","REVBU","REVB"],"gpt_icon":0},{"id":"2601772008","title":"Revelation Biosciences, Inc.盤中異動 下午盤股價大漲6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601772008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601772008?lang=zh_tw&edition=fundamental","pubTime":"2026-01-07 03:39","pubTimestamp":1767728378,"startTime":"0","endTime":"0","summary":"北京时间2026年01月07日03时39分，Revelation Biosciences, Inc.股票出现异动，股价大幅上涨6.08%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，Alumis Inc.、Cyclerion Therapeutics, Inc.、Acrivon Therapeutics, Inc.涨幅较大，Pmgc Holdings Inc.、Cyclerion Therapeutics, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为2398.35%、1780.02%、240.88%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Alumis Inc.，振幅分别为297.37%、161.40%、84.56%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc是一家临床阶段的生命科学公司，专注于通过其专有配方Gemini重新平衡炎症以优化健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107033939953c19da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107033939953c19da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVB","BK4139","REVBU","REVBW"],"gpt_icon":0},{"id":"2587673152","title":"Revelation Biosciences, Inc.盤中異動 早盤股價大漲5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2587673152","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587673152?lang=zh_tw&edition=fundamental","pubTime":"2025-11-28 23:08","pubTimestamp":1764342518,"startTime":"0","endTime":"0","summary":"北京时间2025年11月28日23时08分，Revelation Biosciences, Inc.股票出现异动，股价急速上涨5.34%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc是一家临床阶段的生命科学公司，专注于通过其专有配方Gemini重新平衡炎症以优化健康。Gemini是Revelation的专有配方，为磷酸化的六酰二糖，是一种已知的TLR4激动剂，可以刺激人体的先天免疫反应以预防和治疗疾病。所开发的产品候选者均基于Gemini配方的PHAD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128230838a4c0b647&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128230838a4c0b647&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REVBU","REVBW","REVB"],"gpt_icon":0},{"id":"2583501146","title":"Revelation Biosciences, Inc.盤中異動 下午盤快速下挫5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583501146","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583501146?lang=zh_tw&edition=fundamental","pubTime":"2025-11-14 02:01","pubTimestamp":1763056914,"startTime":"0","endTime":"0","summary":"北京时间2025年11月14日02时01分，Revelation Biosciences, Inc.股票出现异动，股价大幅下挫5.14%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，Mersana Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、冠科美博涨幅较大，Clearmind Medicine Inc.、Salarius Pharmaceuticals, Inc.、Outlook Therapeutics, Inc.较为活跃，换手率分别为5233.34%、465.46%、94.61%，振幅较大的相关个股有Clearmind Medicine Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Outlook Therapeutics, Inc.，振幅分别为107.67%、45.96%、36.72%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc是一家临床阶段的生命科学公司，专注于通过其专有配方Gemini重新平衡炎症以优化健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114020154a6f79401&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114020154a6f79401&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVBW","BK4139","REVB","REVBU"],"gpt_icon":0},{"id":"2578573094","title":"Revelation Biosciences, Inc.盤中異動 股價大漲7.44%報1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2578573094","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578573094?lang=zh_tw&edition=fundamental","pubTime":"2025-10-24 23:32","pubTimestamp":1761319974,"startTime":"0","endTime":"0","summary":"北京时间2025年10月24日23时32分，Revelation Biosciences, Inc.股票出现波动，股价快速上涨7.44%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Theriva Biologics, Inc.、Genenta Science Spa、Inhibrx Biosciences, Inc.涨幅较大，Neuphoria Therapeutics Inc.、Qualigen Therapeutics, Inc.、Theriva Biologics, Inc.较为活跃，换手率分别为3107.40%、2328.53%、1869.33%，振幅较大的相关个股有Theriva Biologics, Inc.、Genenta Science Spa、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为134.04%、133.75%、84.64%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc是一家临床阶段的生命科学公司，专注于通过其专有配方Gemini重新平衡炎症以优化健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102423325494dbdd93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102423325494dbdd93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVBU","BK4139","REVBW","REVB"],"gpt_icon":0},{"id":"2566569768","title":"Revelation Biosciences, Inc.盤中異動 早盤大幅下跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566569768","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566569768?lang=zh_tw&edition=fundamental","pubTime":"2025-09-08 21:33","pubTimestamp":1757338386,"startTime":"0","endTime":"0","summary":"北京时间2025年09月08日21时33分，Revelation Biosciences, Inc.股票出现异动，股价快速下跌5.20%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，Rapport Therapeutics, Inc.、Genprex, Inc.、Ethzilla Corporation C/Wts 06/11/2025涨幅较大，Cdt Equity Inc.、Genprex, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为710.17%、95.21%、63.11%，振幅较大的相关个股有Rapport Therapeutics, Inc.、Genprex, Inc.、Alphaton Capital Corp.，振幅分别为29.72%、24.75%、11.59%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc是一家临床阶段的生命科学公司，专注于通过其专有配方Gemini重新平衡炎症以优化健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025090821330697813eb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025090821330697813eb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVBW","BK4139","REVBU","REVB"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}]}}